
Tiffany A Traina MD
Breast Cancer, Cancer Genetics/Cancer Risk Assessment
Vice Chair, Oncology Care; Department of Medicine Memorial Sloan Kettering Cancer Center Section Head, TNBC Clinical Research Program Breast Medicine Service Associate Professor of Medicine, Weill Cornell Medicine
300 East 66th StreetFloors 1 - 4New York, NY 10065
Overview of Dr. Traina
Dr. Tiffany Traina is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from Weill Cornell Medicine and has been in practice 27 years. Dr. Traina accepts several types of health insurance, listed below. She is one of 529 doctors at Memorial Sloan Kettering Cancer Center and one of 87 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Oncology. She has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
Weill Cornell MedicineClass of 1999
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2020 - 2027
NY State Medical License 2000 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Hally Yacino Steiner Award Susan G Komen Foundation
- Hero Award TNBC Foundation
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
Clinical Trials
- Study of Biweekly Capecitabine Dosing With Bevacizumab for the Treatment of Metastatic Breast Cancer Based Upon the Norton-Simon Mathematical Model
- Bicalutamide in Treating Patients With Metastatic Breast Cancer Start of enrollment: 2007 Mar 23
- Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery
Publications & Presentations
PubMed
- First-line treatment patterns and real-world survival outcomes in PD-L1-negative locally recurrent inoperable or metastatic triple-negative breast cancer in the United...Tiffany A Traina, Elizabeth Serra, Jerome Bedard, Mohira Levesque-Leroux, Patrick Gagnon-Sanschagrin
Breast Cancer Research and Treatment. 2026-08-05 - Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program.Allison Lipitz-Snyderman, Susan Chimonas, Brendan Raftery, Lauren Klein Levine, Cole Manship
JCO Oncology Practice. 2026-04-09 - Correction: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients wi...Eileen Shinn, David Zahrieh, Angela DeMichele, Nick Zdenkowski, Julie Lemieux
Breast Cancer Research and Treatment. 2026-02-18
Press Mentions
Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS CongressApril 26th, 2025
Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)September 25th, 2024
Expert Highlights Evolving Options in HER2+ Breast CancerFebruary 15th, 2018
Committees
- Chair Elect, ASCO Membership Committee 2019 - Present
- TNBC Working Group, Translational Breast Cancer Research Consortium
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:


